• Skills People And Talent

How are companies across the Bruntwood SciTech network improving access to better healthcare, medicines and treatments?

The Bruntwood SciTech network is home to some of the UK’s most pioneering science companies, from small medtech startups and scaleups, all the way through to global life science companies that are uncovering world-leading discoveries, creating new medicines and shaping the future of our healthcare. So who are some of the UK’s most innovative life science businesses at the forefront of helping to create a fairer and healthier world?

Applications invited for Accelerate@Babraham life science start-up competition

Five months, five companies: Life-changing ideas, game-changing support. Accelerate@Babraham, the bio-entrepreneurial incubator initiative founded and developed by the Babraham Research Campus - supported by key industry and investor organisations - opens applications for its 2021/22 cohort today.

QUAY PHARMA WINS QUEEN’S AWARD FOR INDUSTRY

Leading pharmaceutical contract development and manufacturing organisation (CDMO) Quay Pharmaceutical has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success. The company won its award for International Trade.

Discovery Park & National Horizons Centre agree partnership

A partnership between the National Horizons Centre and Discovery Park, the Life Sciences Opportunity Zone for ambitious companies, is promising to bring opportunities to both organisations.

The best in AI appointed at Norwich Research Park

Scientists across Norwich Research Park institutes are part of a major integrated UK research-industry programme led by The Alan Turing Institute, seeking out the best talent in AI and data science, developing bioscience leaders and supporting the UK economy.

Coulter Partners secures Chair of the Board for OxSonics Therapeutics

Coulter Partners was very pleased to partner recently with OxSonics® Therapeutics, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer, to secure the appointment of Dr Allison Jeynes as non-executive Chair of the Board of Directors.

Placement | The RSA Group Completes Search for Clinigen Group – Sharon Curran Appointed as Independent Non-Executive Director

The RSA Group, a leading Life Sciences Executive Search firm, is delighted to announce the placement of Sharon Curran as a new independent Non-Executive Director at Clinigen Group, a global, specialist pharmaceutical services and products platform focused on providing ethical access to medicines.

Boyds appoints Neil Chakrabarti as Chief Financial Officer

Leading pharmaceutical and biotech product development consultancy, Boyds has announced the appointment of Neil Chakrabarti as Chief Financial Officer. The appointment comes as the company reported a record-breaking 25 percent growth in turnover as demand for its specialist services continues to grow.

Medannex sweeps the board at Scotland’s Life Sciences Annual Awards

Medannex Ltd (Edinburgh) this week received multiple awards in recognition of notable successes in several key areas. The late-stage biopharmaceutical company, developing novel treatments for cancers and autoimmune diseases, was declared the winner in all three categories in which it was nominated at Scotland’s Life Sciences Annual Awards.

Boyds launches recruitment drive following surge in growth

Turnover at leading pharmaceutical and biotech product development consultancy Boyds has surged by a record-breaking 25 percent as demand for its specialist services continues to grow.